Fundraising FoxPoxel
Lyon, FR · 4 known investors
Find your way into Poxel
Sign up to see every warm intro you have to Poxel
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Poxel team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Poxel is a clinical-stage biopharmaceutical company developing treatments for chronic metabolic diseases, including metabolic dysfunction-associated steatohepatitis and rare genetic disorders. The company is advancing drug candidates targeting metabolic pathways and has one approved product marketed in Japan.
Investors · 4
How we know: Andera Partners's portfolio page · Not right? Tell us
How we know: funding news · globenewswire.com · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries B extensionSep 2014
Edmond de Rothschild Investment Partners (EdRIP) (lead), Kreos Capital, the Large Venture investment division of Bpifrance
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Poxel do?
- Poxel is a clinical-stage biopharmaceutical company developing treatments for chronic metabolic diseases, including metabolic dysfunction-associated steatohepatitis and rare genetic disorders. The company is advancing drug candidates targeting metabolic pathways and has one approved product marketed in Japan.
- Who are Poxel's investors?
- Poxel's investors include Andera Partners, Kreos Capital.
- Where is Poxel headquartered?
- Poxel is headquartered in Lyon, FR.